SCHEMBL5199100

SCHEMBL5199100

CC([C]=O)C(O)C[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5840281 0.78
SCHEMBL5544206 0.78
SCHEMBL28497357 0.78
SCHEMBL11137576 0.77
SCHEMBL6603736 0.77
SCHEMBL11529015 0.77
SCHEMBL5665686 0.76
SCHEMBL19514784 0.74
SCHEMBL28241650 0.74
SCHEMBL4399342 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251135-A1 FORMULATION FOR TREATING CHOLESTEROL Specchiasol S.r.l. (IT) 2023-10-04 EP disclosed
WO-2022113140-A1 FORMULATION FOR TREATING CHOLESTEROL SPECCHIASOL S.R.L. (IT) 2022-06-02 WO disclosed
CN-110090319-A Bone implant constituent and preparation method thereof with ostosis ability 和康生物科技股份有限公司 2019-08-06 CN disclosed
US-20190231926-A1 BONE GRAFT COMPOSITION WITH OSTEOGENIC CAPACITY MAXIGEN BIOTECH INC. (TW) 2019-08-01 US disclosed
EP-1818056-A1 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-08-15 EP disclosed